Literature DB >> 19716046

Whole blood genomic biomarkers of acute cardiac allograft rejection.

David Lin1, Zsuzsanna Hollander, Raymond T Ng, Carol Imai, Andrew Ignaszewski, Robert Balshaw, Gabriela Cohen Freue, Janet E Wilson-McManus, Pooran Qasimi, Anna Meredith, Alice Mui, Tim Triche, Robert McMaster, Paul A Keown, Bruce M McManus.   

Abstract

BACKGROUND: Significant progress has been made in cardiac transplantation over the past 30 years; however, the means for detection of acute cardiac allograft rejection remains in need of improvement. At present, the endomyocardial biopsy, an invasive and inconvenient procedure for patients, is required for the surveillance and diagnosis of acute cardiac allograft rejection. In the Biomarkers in Transplantation initiative, we investigated gene expression profiles in peripheral blood of cardiac transplant subjects as potential biomarkers for diagnosis of allograft rejection.
METHODS: Whole blood samples were obtained from 28 cardiac transplant subjects who consented to the study. Serial samples were collected from pre-transplant through 3 years post-transplant according to the standard protocol. Temporally correspondent biopsies were also collected, reviewed in a blinded manner, and graded according to current ISHLT guidelines. Blood samples were analyzed using Affymetrix microarrays. Genomic profiles were compared in subjects with acute rejection (AR; ISHLT Grade > or =2R) and no rejection (NR; Grade 0R). Biomarker panel genes were identified using linear discriminant analysis.
RESULTS: We found 1,295 differentially expressed probe-sets between AR and NR samples and developed a 12-gene biomarker panel that classifies our internal validation samples with 83% sensitivity and 100% specificity.
CONCLUSIONS: Based on our current results, we believe whole blood genomic biomarkers hold great potential in the diagnosis of acute cardiac allograft rejection. A prospective, Canada-wide trial will be conducted shortly to further evaluate the classifier panel in diverse patients and a range of clinical programs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716046     DOI: 10.1016/j.healun.2009.04.025

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  17 in total

Review 1.  Molecular diagnostics in transplantation.

Authors:  Maarten Naesens; Minnie M Sarwal
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

2.  Universal noninvasive detection of solid organ transplant rejection.

Authors:  Thomas M Snyder; Kiran K Khush; Hannah A Valantine; Stephen R Quake
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

3.  Identification of Candidate Biomarkers for Transplant Rejection from Transcriptome Data: A Systematic Review.

Authors:  Sheyla Velasques Paladini; Graziela Hünning Pinto; Rodrigo Haas Bueno; Raquel Calloni; Mariana Recamonde-Mendoza
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 4.  Assessing the human immune system through blood transcriptomics.

Authors:  Damien Chaussabel; Virginia Pascual; Jacques Banchereau
Journal:  BMC Biol       Date:  2010-07-01       Impact factor: 7.431

5.  Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.

Authors:  R C Starling; J Stehlik; D A Baran; B Armstrong; J R Stone; D Ikle; Y Morrison; N D Bridges; P Putheti; T B Strom; M Bhasin; I Guleria; A Chandraker; M Sayegh; K P Daly; D M Briscoe; P S Heeger
Journal:  Am J Transplant       Date:  2015-08-10       Impact factor: 8.086

6.  Gene expression profiling of human whole blood samples with the Illumina WG-DASL assay.

Authors:  Mary E Winn; Marian Shaw; Craig April; Brandy Klotzle; Jian-Bing Fan; Sarah S Murray; Nicholas J Schork
Journal:  BMC Genomics       Date:  2011-08-15       Impact factor: 3.969

7.  White blood cell differentials enrich whole blood expression data in the context of acute cardiac allograft rejection.

Authors:  Casey P Shannon; Zsuzsanna Hollander; Janet Wilson-McManus; Robert Balshaw; Raymond T Ng; Robert McMaster; Bruce M McManus; Paul A Keown; Scott J Tebbutt
Journal:  Bioinform Biol Insights       Date:  2012-04-10

8.  Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.

Authors:  Gabriela V Cohen Freue; Anna Meredith; Derek Smith; Axel Bergman; Mayu Sasaki; Karen K Y Lam; Zsuzsanna Hollander; Nina Opushneva; Mandeep Takhar; David Lin; Janet Wilson-McManus; Robert Balshaw; Paul A Keown; Christoph H Borchers; Bruce McManus; Raymond T Ng; W Robert McMaster
Journal:  PLoS Comput Biol       Date:  2013-04-04       Impact factor: 4.475

9.  A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers.

Authors:  Oliver P Günther; Virginia Chen; Gabriela Cohen Freue; Robert F Balshaw; Scott J Tebbutt; Zsuzsanna Hollander; Mandeep Takhar; W Robert McMaster; Bruce M McManus; Paul A Keown; Raymond T Ng
Journal:  BMC Bioinformatics       Date:  2012-12-08       Impact factor: 3.169

Review 10.  Computational Models for Transplant Biomarker Discovery.

Authors:  Anyou Wang; Minnie M Sarwal
Journal:  Front Immunol       Date:  2015-09-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.